LONDON, March 07, 2023 (GLOBE NEWSWIRE) — Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-duration psychedelic-assisted therapies for mental health conditions, today announces that it will host a virtual Key Opinion Leader roundtable with Jerry Rosenbaum, MD, Professor of Psychiatry at Harvard Medical School…


Previous articleMind the Gap: The Importance of Gender Equity in Psychedelic Clinical Trials
Next articlePT396 – Moms on Mushrooms: Motherhood and Psychedelics Inside a Broken Culture